Biocon Ltd. is a holding company, which engages in the manufacture, research, and development of therapeutic drugs. It operates through the following segments: Small Molecules, Biologics, Branded Formulations, and Research Services. The Small Molecules segment manufactures spanning statins, immunosuppressants, antifungals, anti-obesity, anti-diabetics, ophthalmologicals, oncologicals, and urologicals etc. The Biologics segment provides Insulins and Analogs, biosimilar Monoclonal Antibodies (MAbs), and recombinant proteins The Branded Formulation segment consists of therapeutic areas of diabetology, oncology, immunology and critical care. The Research Services segment covers Syngene development platforms. The company was founded by Kiran Mazumdar-Shaw on November 29, 1978 and is headquartered in Bangalore, India.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Biocon Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Biocon Ltd. market cap is 570.9B.
What is the 52-week high for Biocon Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Biocon Ltd. 52 week high is 424.95 as of April 04, 2026.
What is the 52-week low for Biocon Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Biocon Ltd. 52 week low is 299.00 as of April 04, 2026.
What is Biocon Ltd. stock price today?
Biocon Ltd. stock price today is 352.00.
What was Biocon Ltd. stock price yesterday?
Biocon Ltd. stock price yesterday was 364.60.
What is the PE ratio of Biocon Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Biocon Ltd.'s P/E ratio is 72.89.
What is the Price-to-Book ratio of Biocon Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Biocon Ltd. P/B ratio is 1.7296.
What is the 50-day moving average of Biocon Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Biocon Ltd. 50-day moving average is 376.81.